Get up to speed on drug markets - without doing research

Clinical trial results, historical drug revenue, valuation models and more – delivered in 24 hours

$100 per drug analyzed. See exact pricing before you buy.

Comprehensive data on disease markets

Comprehensive market analysis with just a click
Track market growth with quarterly historical revenue for major drugs
Clinical trial results aggregated and analyzed
Instant valuation models for key approved drugs, exportable to excel
Market sizing for each approved drug, with sourced epidemiology and pricing data
Free revision if we miss a key data point

See what's in a report

Get up to speed on drug markets with the click of a button.

Reports include disease descriptions, epidemiology data, clinical trial results for major pivotal studies, historical quarterly revenue for approved drugs, drug pricing, market sizing for each drug, and rNPV valuation models for approved drugs.

Reports currently cover approved drugs only. We will be adding pipeline coverage shortly. Reports are generated with AI, leveraging high quality data sources like the FDA Orange Book, drug labels, peer-reviewed articles, company filings, and more.

To learn more, click to view a full sample.

Spinal Muscular Atrophy Dashboard

A genetic neuromuscular disorder characterized by progressive muscle weakness and atrophy due to degeneration of motor neurons in the spinal cord.

Total WW Revenue of Select Branded Drugs (FY 2025E)
$4,542M
CAGR of Select Branded Drugs (2025-2030)
-3.3%
US Prevalence
4,900-9,301
US List Price Per Patient Per Year
Avg: $971,667 Range: $340,000-$2,125,000

Drug Valuation Analysis

Drug Name Mechanism Company
AI Value ($M)
Download rNPV model
FDA Approved Drugs
3 drugs
Zolgensma
Gene therapy Novartis
$2377
Evrysdi
Small molecule: Survival of Motor Neuron 2 Splicing Modifier Roche
$7368
Spinraza
Oligonucleotide therapies: Survival Motor Neuron-2-directed RNA Interaction Biogen
$5531

Data last updated: May 19, 2025 | Values in millions of USD

Need something bespoke? → Book a 10-min call

How It Works

1. Select an indication

Search for your disease area of interest in our comprehensive database of therapeutic indications.

2. Review pricing

See transparent pricing based on the number of drugs in your report. Each drug costs $100.

3. Place your order

Securely check out with a credit card. No subscription required.

4. Receive your report

Your custom report will be delivered to your inbox in less than 24 hours, complete with Excel exports.

Frequently Asked Questions

🛡️ Quality guarantee

If we miss a key drug or critical datapoint, we'll revise the report free within 7 days

How accurate is the data in AI-generated reports?
Our AI reports analyze information from reputable medical journals, clinical trial databases, company filings, and other reliable sources. While we strive for accuracy, AI-generated reports should be used as a starting point for research. We recommend verifying critical data points against primary sources.
How quickly will I receive my report?
All reports are delivered within one-two business days of order confirmation. You'll receive your report via email, and it will also be available in your account dashboard for future reference.
What drugs are included?
We currently cover FDA approved drugs only. Coverage of pipeline drugs is coming soon.
How is pricing determined?
Pricing is simple: $100 per drug analyzed. A report covering 5 drugs costs $500, 10 drugs costs $1,000, and so on. You'll see the exact list of drugs and final price before checkout.
Can I request custom analyses for specific questions?
Yes, we can customize reports to address specific questions or focus areas. Contact our team after placing your order to discuss your specific requirements, and we'll work to incorporate them into your report.